Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (18,816,628)	$ (14,247,124)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	277,178	480,187
Amortization	20,140	3,294
Amortization of right-of-use assets	574,682	424,504
Accounts receivable reserve	8,000	0
Loss on fixed asset dispositions	676	47,538
Share-based compensation expense	444,147	675,700
Amortization of debt issuance costs and discount	1,192,574	107,963
Changes in operating assets and liabilities:
Accounts receivable	(397,467)	(21,436)
Inventory	(2,379,205)	(230,395)
Prepaid and other assets	(139,136)	282,169
Accounts payable	207,481	627,065
Accrued expenses	6,753	987,582
Lease liabilities	(406,636)	(440,489)
Other liabilities	(36,568)	22,896
Net cash used in operating activities	(19,444,009)	(11,280,546)
Cash flows from investing activities:
Acquisition of patents	(86,058)	0
Purchases of property and equipment	(761,706)	(143,917)
Net cash used in investing activities	(847,764)	(143,917)
Cash flows from financing activities:
Proceeds from the issuance of common stock and warrants in April 2023 Financing	0	3,899,813
Equity issuance costs for April 2023 Financing	0	(547,764)
Proceeds from convertible notes, including related parties	0	6,850,000
Issuance costs for convertible notes, including related parties	0	(525,144)
Proceeds from exercise of pre-funded warrants	0	188
Proceeds from exercise of common warrants	0	3,687,976
Proceeds from common stock issued through ESPP	63,106	4,955
Proceeds from at-the-market sales of common stock	2,025,104	7,665,066
Issuance costs for at-the-market sales of common stock	(60,753)	(229,953)
Repayment of note payable	0	(610,340)
Payments under lease obligations	0	(16,193)
Net cash provided by financing activities	2,027,457	20,178,604
Net change in cash and cash equivalents	(18,264,316)	8,754,141
Cash and cash equivalents:
Beginning of period	21,716,077	12,961,936
End of period	3,451,761	21,716,077
Cash paid for:
Interest	111,000	9,903
Taxes	5,708	4,550
Non-cash investing and financing activities:
Right-of-use asset obtained in exchange for a lease liability	0	2,496,968
Property and equipment costs included in accounts payable	73,740	0
Fair value of warrants issued in connection with convertible notes	0	2,219,165
Payment of convertible note interest in common stock	300,000	0
Deferred offering costs reclassified to additional paid-in-capital	$ 3,143	$ 17,952